Tag: Sputnik V

India’s production, Russia’s export of Sputnik vaccine at risk due to Ukraine crisis

India's production and exports of Russia's Sputnik COVID-19 vaccines are expected to slow further following U.S. sanctions on Russia's...

Markus Soeder: Sputnik V vaccine project in Bavaria is closed

Bavaria will block the production of Russia's Sputnik COVID-19 vaccine even if it is approved by the European Medicines...

Vaccine against COVID Sputnik V granted full permanent approval in Russia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus...

Russia and China are working on mutual recognition of COVID-19 vaccines

Earlier, the Russian Ministry of Economic Development announced that Russia had made agreements with six Chinese manufacturers for the...

Argentina displays interest in nasal form of Russia’s Sputnik V vaccine

Argentina has displayed an interest in the nasal form of Russia's Sputnik V coronavirus vaccine and other Russian developments...

Spallanzani Institute in Italy: Sputnik V shows higher Omicron-antibody levels than Pfizer in preliminary study

The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund (RDIF, Russia’s...

Australia has recognized Russia’s Sputnik V COVID-19 vaccine for international travellers

International travellers who have had two doses of the Russian Sputnik V vaccine will be permitted to enter Australia...

Binnopharm Group and Sartorius partner to manufacture biotechnological medicines and vaccines against COVID-19

Binnopharm Group (part of Sistema) and Sartorius, one of the leading global manufacturers of equipment for the biopharmaceutical industry,...

Sputnik V demonstrates 94.8% efficacy against COVID during the vaccination in San Marino

The Russian Direct Investment Fund (RDIF) announces the real world data of the Ministry of Health of San Marino...

Laboratorios Richmond delivers the first batch of over 1M doses of the Sputnik V produced in Argentina

Locally produced Sputnik V was supervised and verified by the National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT).

Official data from leading countries confirms the Sputnik V vaccine’s high safety and efficacy profile

To date Sputnik V has been approved in 69 countries with total population exceeding 3.7 billion people - nearly half of the global population.

Pre-clinical trials of intranasal version of Sputnik V completed

The vaccine helps to develop a local immunity, therefore it will be most likely recommended to those who have contraindications to injections.